Gezielt nachschlagen
Suche
Suche startet nach einer kurzen Eingabepause.
16 angezeigte Treffer · Seite 2, keine Gesamtzahl für „Cyramza“
Suchtreffer
Begriffe & Kennungen
Cyramza · 4.8 · Reporting of suspected adverse reactions
Eintrag öffnenCyramza · 4.8 · Reporting suspected adverse reactions after authorisation of the medicinal product is important. It allows con
Eintrag öffnenCyramza · 4.8 · Summary of the safety profile
Eintrag öffnenCyramza · 4.8 · System Organ Class Common Uncommon Rare Not known (MedDRA) Neoplasms benign, Haemangioma malignant and unspeci
Eintrag öffnenCyramza · 4.8 · System Organ Class Very Common Common Uncommon (MedDRA) Infections and infestations Infectionsj,k Sepsisa,b Bl
Eintrag öffnenCyramza · 4.8 · System Organ Very Common Common Uncommon Class (MedDRA) Blood and Thrombocytopeniaa Neutropeniaa lymphatic sys
Eintrag öffnenCyramza · 4.8 · Table 6: ADRs reported in patients treated with ramucirumab as monotherapy in phase 3 clinical trials (REGARD,
Eintrag öffnenCyramza · 4.8 · Table 8: ADRs associated with ramucirumab reported in clinical trials and through post- marketing reporting
Eintrag öffnenCyramza · 4.8 · Tables 6 and 7 below list the adverse drug reactions (ADRs) from placebo controlled phase III clinical trials
Eintrag öffnenCyramza · 4.8 · Tabulated list of adverse reactions
Eintrag öffnenCyramza · 4.8 · The following convention has been used for classification of frequency for ADR tables:
Eintrag öffnenCyramza · 4.8 · The most common adverse reactions observed in patients treated with ramucirumab as monotherapy are: peripheral
Eintrag öffnenCyramza · 4.8 · The most common adverse reactions observed in patients treated with ramucirumab in combination with chemothera
Eintrag öffnenCyramza · 4.8 · The most common adverse reactions observed in patients treated with ramucirumab in combination with erlotinib
Eintrag öffnenCyramza · 4.8 · The most serious adverse reactions associated with ramucirumab treatment (as a single agent or in combination
Eintrag öffnenCyramza · 4.8 · Very common (≥ 1/10) Common (≥ 1/100 to < 1/10) Uncommon (≥ 1/1 000 to < 1/100) Rare (≥ 1/10 000 to < 1/1 000)
Eintrag öffnen